CoChat

GRHL2 motif is associated with intratumor heterogeneity of cis-regulatory elements in luminal breast cancer

Open access

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Abstract

In breast cancer patients, tumor heterogeneity is associated with prognosis and therapeutic response; however, the epigenetic diversity that exists in primary tumors remains unknown. Using a single-cell sequencing assay for transposase-accessible chromatin (scATAC-seq), we obtained the chromatin accessibility profiles of 12,452 cells from 16 breast cancer patients including 11 luminal, 1 luminal-HER2, 1 HER2+, and 3 triple-negative subtypes. Via this profiling process, tumors were classified into cancer cells and the tumor microenvironment, highlighting the heterogeneity of disease-related pathways including estrogen receptor (ER) signaling. Furthermore, the coexistence of cancer cell clusters with different ER binding motif enrichments was identified in a single ER+ tumor. In a cluster with reduced ER motif enrichment, we identified GRHL2, a transcription factor, as the most enriched motif, and it cooperated with FOXA1 to initiate endocrine resistance. Coaccessibility analysis revealed that GRHL2 binding elements potentially regulate genes associated with endocrine resistance, metastasis, and poor prognosis in patients that received hormonal therapy. Overall, our study suggests that epigenetic heterogeneity could lead to endocrine resistance and poor prognosis in breast cancer patients and it offers a large-scale resource for further cancer research.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41523-022-00438-6

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Single-cell chromatin accessibility of human breast cancer tissues. a Schema of collecting samples and analysis. b Uniform manifold approximation and projection (UMAP) after iterative latent semantic indexing of 12,452 cell scATAC-seq profiles from 16 human breast cancer patients. Each dot represents a single cell colored by its corresponding cluster. Each cluster number is presented on the UMAP. Each cluster annotation is labeled to the right of the UMAP. c The same UMAP projection is shown in a but with each cell colored by its corresponding patient. Immunohistochemistry scores and breast cancer subtypes are presented on the right of the UMAP. Allred score was used for estrogen and progesterone receptors: ≥3 is considered positive. P20N data were from the primary site diagnosis. Pathological subtypes of each patient are shown as follows: TN triple-negative, LM luminal, HR HER2-positive, and LH luminal-HER2. d Marker gene activity score and TF motif scores for each cluster. e Aggregated ATAC signal tracks showing the chromatin accessibility peaks of approximate transcription start sites of marker genes for each cluster. Positive-strand genes are colored in red and negative-strand genes are colored in blue. f Heatmap of Z-score of 47,406 cell-type-specific CREs for each cluster. g Heatmap of adjusted P value of motif enrichment for each CREs in f. h Bar plots of top three enriched GO terms calculated by GREAT for each CREs in f.
Fig. 1 Single-cell chromatin accessibility of human breast cancer tissues. a Schema of collecting samples and analysis. b Uniform manifold approximation and projection (UMAP) after iterative latent semantic indexing of 12,452 cell scATAC-seq profiles from 16 human breast cancer patients. Each dot represents a single cell colored by its corresponding cluster. Each cluster number is presented on the UMAP. Each cluster annotation is labeled to the right of the UMAP. c The same UMAP projection is shown in a but with each cell colored by its corresponding patient. Immunohistochemistry scores and breast cancer subtypes are presented on the right of the UMAP. Allred score was used for estrogen and progesterone receptors: ≥3 is considered positive. P20N data were from the primary site diagnosis. Pathological subtypes of each patient are shown as follows: TN triple-negative, LM luminal, HR HER2-positive, and LH luminal-HER2. d Marker gene activity score and TF motif scores for each cluster. e Aggregated ATAC signal tracks showing the chromatin accessibility peaks of approximate transcription start sites of marker genes for each cluster. Positive-strand genes are colored in red and negative-strand genes are colored in blue. f Heatmap of Z-score of 47,406 cell-type-specific CREs for each cluster. g Heatmap of adjusted P value of motif enrichment for each CREs in f. h Bar plots of top three enriched GO terms calculated by GREAT for each CREs in f.CC BY · PubMed Central
Fig. 2 Chromatin landscape of breast cancer cells. a, b UMAP of subclustering of 4141 epithelial cells, colored according to corresponding epithelial clusters in a and corresponding patients in b. In a, cluster number is shown on the UMAP. Sample details shown to the right of b are identical to those shown in Fig. 1b. c Inferred copy number variations of 4141 epithelial cells from scATAC-seq data. The log2(fold change) to GC-matched background was calculated and normalized by the same scores for TME cells. Clusters and samples of each cells were represented on the left side of the heatmap. d Heatmap of Z-score of marker gene activity score. e–g Aggregated ATAC signal tracks showing chromatin accessibility peaks of approximate transcription start sites of luminal or TNBC markers in e, HER2 associated genes in f, and epithelial to mesenchymal transition markers in g for each cancer cluster. h Most variable 50 TF motif scores for each cancer cluster.
Fig. 2 Chromatin landscape of breast cancer cells. a, b UMAP of subclustering of 4141 epithelial cells, colored according to corresponding epithelial clusters in a and corresponding patients in b. In a, cluster number is shown on the UMAP. Sample details shown to the right of b are identical to those shown in Fig. 1b. c Inferred copy number variations of 4141 epithelial cells from scATAC-seq data. The log2(fold change) to GC-matched background was calculated and normalized by the same scores for TME cells. Clusters and samples of each cells were represented on the left side of the heatmap. d Heatmap of Z-score of marker gene activity score. e–g Aggregated ATAC signal tracks showing chromatin accessibility peaks of approximate transcription start sites of luminal or TNBC markers in e, HER2 associated genes in f, and epithelial to mesenchymal transition markers in g for each cancer cluster. h Most variable 50 TF motif scores for each cancer cluster.CC BY · PubMed Central
Fig. 3 Integrative analysis of previously reported scRNA-seq results and our scATAC-seq data. a, b UMAP of subclustering of the epithelial cell transcriptome reported in a previous scRNA-seq study (Pal et al., 2021), colored according to the corresponding epithelial clusters in a and corresponding samples in b. c Heatmap of scaled expression of marker genes. d Breast cancer subtype composition of each epithelial cluster, according to the scRNA-seq. e Heatmap of scaled expression of genes corresponding to the results in Fig. 2e–g. Unlike panel in c, the cells are grouped by sample and average scaled expression is presented. f UMAP visualization of 4,141 epithelial chromatin profiles, colored according to the linked scRNA-seq clusters presented in panel a. Based on gene activity scores, scATAC-seq cells were linked to scRNA-seq exhibiting a similar expression pattern. g Subtype composition of scRNA-seq cells associated with each scATAC-seq cluster.
Fig. 3 Integrative analysis of previously reported scRNA-seq results and our scATAC-seq data. a, b UMAP of subclustering of the epithelial cell transcriptome reported in a previous scRNA-seq study (Pal et al., 2021), colored according to the corresponding epithelial clusters in a and corresponding samples in b. c Heatmap of scaled expression of marker genes. d Breast cancer subtype composition of each epithelial cluster, according to the scRNA-seq. e Heatmap of scaled expression of genes corresponding to the results in Fig. 2e–g. Unlike panel in c, the cells are grouped by sample and average scaled expression is presented. f UMAP visualization of 4,141 epithelial chromatin profiles, colored according to the linked scRNA-seq clusters presented in panel a. Based on gene activity scores, scATAC-seq cells were linked to scRNA-seq exhibiting a similar expression pattern. g Subtype composition of scRNA-seq cells associated with each scATAC-seq cluster.CC BY · PubMed Central
Fig. 4 Gene activity signatures of FOXA1 and ER targets. a, b Aggregated ATAC signal tracks around TSS (left), gene activity scores (center), and motif enrichment scores (right) of FOXA1 in a and ESR1 in b for each cancer cluster. c, d Aggregated ATAC signal tracks around TSSs of the represented targets (left) and signature scores (right) of genes targeted by FOXA1 in c, ER in d for each cancer cluster.
Fig. 4 Gene activity signatures of FOXA1 and ER targets. a, b Aggregated ATAC signal tracks around TSS (left), gene activity scores (center), and motif enrichment scores (right) of FOXA1 in a and ESR1 in b for each cancer cluster. c, d Aggregated ATAC signal tracks around TSSs of the represented targets (left) and signature scores (right) of genes targeted by FOXA1 in c, ER in d for each cancer cluster.CC BY · PubMed Central
Fig. 5 GRHL2 was associated with less ER dependency leading to the intratumor heterogeneity of a single luminal tumor. a Volcano plot representing differential motif enrichment between Ep10 and Ep11 from a single luminal tumor. b Heatmap of aggregated ATAC-seq signal in a 2 kb window, divided according to a significantly higher signal in Ep11 or in Ep10. Pie charts show the numbers of Ep10- or Ep11-specific peaks with or without GRHL2-binding motifs. The bar plot represents hypergeometric tests of GRHL2 motif enrichment in each CRE set. c Schema for identifying peak-gene associations (left), and genome accessibility track of the FGFR2 region with peak coaccessibility (right). The red band indicates the Ep10-specific element with GRHL2 motif potentially interacting FGFR2 coding region. d Pearson’s correlation between TCGA-BRCA ATAC-seq normalized counts and RNA-seq transcripts per million of each peak-gene pair. e, f RNA-seq gene expression of KCNN4 in e or IGF1R in f and normalized ATAC-seq signal of paired peaks in 74 TCGA-BRCA samples. Each dot represents each patient. g Signature scores of putative target genes by Ep10-specific CREs with GRHL2 motifs in Ep10 (N = 281) and Ep11 (N = 327). Wilcoxon rank-sum test was used for significant analysis (p < 2.2e-16). h, i Kaplan–Meier analysis of overall survival of the METABRIC ER+HER2− patient cohort (n = 1,355) with (n = 968, h) or without (n = 387, i) hormone therapy stratified by putative GRHL2 target genes; top 33% versus the bottom 33%, mean of Z-score of expression.
Fig. 5 GRHL2 was associated with less ER dependency leading to the intratumor heterogeneity of a single luminal tumor. a Volcano plot representing differential motif enrichment between Ep10 and Ep11 from a single luminal tumor. b Heatmap of aggregated ATAC-seq signal in a 2 kb window, divided according to a significantly higher signal in Ep11 or in Ep10. Pie charts show the numbers of Ep10- or Ep11-specific peaks with or without GRHL2-binding motifs. The bar plot represents hypergeometric tests of GRHL2 motif enrichment in each CRE set. c Schema for identifying peak-gene associations (left), and genome accessibility track of the FGFR2 region with peak coaccessibility (right). The red band indicates the Ep10-specific element with GRHL2 motif potentially interacting FGFR2 coding region. d Pearson’s correlation between TCGA-BRCA ATAC-seq normalized counts and RNA-seq transcripts per million of each peak-gene pair. e, f RNA-seq gene expression of KCNN4 in e or IGF1R in f and normalized ATAC-seq signal of paired peaks in 74 TCGA-BRCA samples. Each dot represents each patient. g Signature scores of putative target genes by Ep10-specific CREs with GRHL2 motifs in Ep10 (N = 281) and Ep11 (N = 327). Wilcoxon rank-sum test was used for significant analysis (p < 2.2e-16). h, i Kaplan–Meier analysis of overall survival of the METABRIC ER+HER2− patient cohort (n = 1,355) with (n = 968, h) or without (n = 387, i) hormone therapy stratified by putative GRHL2 target genes; top 33% versus the bottom 33%, mean of Z-score of expression.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 46 references

Cited by

See all 50

Metadata

Authors
Kumegawa, K., Takahashi, Y., Saeki, S., Yang, L., Nakadai, T., Osako, T., Mori, S., Noda, T., Ohno, S., Ueno, T., & Maruyama, R.
Affiliations
  • Japanese Foundation For Cancer Research (JP)
  • The Cancer Institute Hospital (JP)
Corresponding author
Maruyama, Reo
Venue
npj Breast Cancer
Published
2022-06-08
Volume
8
Issue
1
Pages
70-70
ISSN
2374-4677 (ISSN-L)
OpenAlex
W4281754371
Cited by
45
References
46
Citations by year
2026: 12 · 2025: 8 · 2024: 19 · 2023: 6
FWCI
2.78
Type
journal article
Language
en
Open access
Licence
Locations
  • npj Breast Cancer (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Japan Agency for Medical Research and Development (21fk0210054h0003, JP21fk0210092)
  • Japan Society for the Promotion of Science (22K07161, 17K18336, 17K10568, 21H02793, 21K06898, 20K07708)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
Keywords
GRHL2, luminal breast cancer, intratumoral heterogeneity, cis-regulatory elements, chromatin accessibility, estrogen receptor signaling, endocrine therapy resistance, FOXA1, tumor microenvironment, single-cell ATAC-seq, HER2-positive breast cancer, triple-negative breast cancer, metastasis, prognosis, hormone therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: GRHL2 motif is associated with intratumor heterogeneity of cis-regulatory elements in luminal breast cancer. https://app.cochat.ai/papers/10.1038/s41523-022-00438-6
The paper
Kumegawa, K., Takahashi, Y., Saeki, S., Yang, L., Nakadai, T., Osako, T., Mori, S., Noda, T., Ohno, S., Ueno, T., & Maruyama, R. (2022). GRHL2 motif is associated with intratumor heterogeneity of cis-regulatory elements in luminal breast cancer. npj Breast Cancer. https://doi.org/10.1038/s41523-022-00438-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.